Cwm, LLC Nrx Pharmaceuticals, Inc. Transaction History

Cwm, LLC

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$4.5 - $11.91 $1,440 - $3,811	-320 Closed	0 $0
Q1 2021 Sep 15, 2021	BUY	$22.85 - $62.71 $7,312 - $20,067	320 New	320 $4,000
Q1 2021 Apr 27, 2021	SELL	$22.85 - $62.71 $7,312 - $20,067	-320 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$10.74 - $38.36 $3,436 - $12,275	320 New	320 $4,000
Q4 2020 Jan 27, 2021	SELL	$10.74 - $38.36 $3,436 - $12,275	-320 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$10.5 - $11.0 $3,360 - $3,520	320 New	320 $4,000
Q3 2020 Oct 19, 2020	SELL	$10.5 - $11.0 $3,360 - $3,520	-320 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$10.5 - $11.85 $3,360 - $3,792	320 New	320 $4,000
Q2 2020 Jul 22, 2020	SELL	$10.5 - $11.85 $3,360 - $3,792	-320 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$10.45 - $11.63 $3,344 - $3,721	320 New	320 $4,000
Q1 2020 Apr 28, 2020	SELL	$10.45 - $11.63 $3,344 - $3,721	-320 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$10.46 - $10.74 $3,347 - $3,436	320 New	320 $4,000
Q4 2019 Jan 27, 2020	SELL	$10.46 - $10.74 $3,347 - $3,436	-320 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$10.3 - $10.6 $3,296 - $3,392	320 New	320 $4,000
Q3 2019 Oct 22, 2019	SELL	$10.3 - $10.6 $3,296 - $3,392	-320 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$10.33 - $10.8 $3,305 - $3,456	320 New	320 $4,000
Q2 2019 Jul 31, 2019	SELL	$10.33 - $10.8 $3,305 - $3,456	-320 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$10.16 - $10.35 $3,251 - $3,312	320 New	320 $0

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $111M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.